Patent details

Basic Information

Publication number:

EP1019078

PCT Application Number:

PCT/SE/98/00682

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP989178967

PCT Publication Number:

WO/98/04625

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

French Title of Invention:

UTILISATION D'UNE PROTEINE OLIGOMERIQUE DE CARTILAGE POUR LE TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE

German Title of Invention:

VERWENDUNG VON OLIGOMEREM MATRIXPROTEIN AUS KNORPEL ZUR BEHANDLUNG VON RHEUMATOIDER ARTHRITIS

SPC Number:

Dates

Filing date:

14/04/1998

Grant date:

23/07/2003

EP Publication Date:

23/07/2003

PCT Publication Date:

22/10/1998

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/07/2000

EP B1 Publication Date:

23/07/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2004

Expiration date:

14/04/2018

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/04/1998

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

LORENTZEN Johnny, C.

Address:

Sweden (SE)

2

Name:

KLARESKOG Lars

Address:

Sweden (SE)

3

Name:

HEINEGARD Dick Lunds Universitet Dept. of Cell

Address:

Sweden (SE)

Priority

Priority Number:

9701409

Priority Date:

15/04/1997

Priority Country:

Sweden (SE)

Classification

Main IPC Class:

A61K 38/17;

Filing date	Document type	Number of pages